Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.

Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.

Item
http://www.wikidata.org/entity/Q35582706
The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification systemComputerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes.DNA ploidy analysis in histopathology. Morphometry and DNA cytometry reproducibility conditions and clinical applications.Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium.Ploidy in gynaecological cancers.DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometriumClinical value of DNA content assessment in endometrial cancer.Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.Clinical significance of Sam68 expression in endometrial carcinoma.Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.
P2860

Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.

Item
http://www.wikidata.org/entity/Q35582706
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Prospective multicenter valida ...... 1 and 2 endometrial carcinoma.
@ast
Prospective multicenter valida ...... 1 and 2 endometrial carcinoma.
@en
type
label
Prospective multicenter valida ...... 1 and 2 endometrial carcinoma.
@ast
Prospective multicenter valida ...... 1 and 2 endometrial carcinoma.
@en
prefLabel
Prospective multicenter valida ...... 1 and 2 endometrial carcinoma.
@ast
Prospective multicenter valida ...... 1 and 2 endometrial carcinoma.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Prospective multicenter valida ...... 1 and 2 endometrial carcinoma.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921